OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
June 02, 2009
Misleading the public about their investments-be it money or medicine-is unacceptable.
It can take a lot of work to make sure nothing happens.
Debates about science, manufacturing, and European regulations will shape the approval process for follow-on biologics in the United States.
June 01, 2009
Today, approximately 1.5 million counterfeit medicine packs enter the legal supply chain each year - in other words, one pack in every 20000 is counterfeit.
May 28, 2009
Also, Johnson & Johnson acquires Cougar Biotechnology; NIH launches program for rare and neglected diseases; PPD restructures leadership positions; more...
May 21, 2009
Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO; more...
May 14, 2009
The first project report on FDA's Sentinel website, discusses the evaluation of existing methods for safety signal identification.
On May 7, 2009, as part of the President's fiscal year (FY) 2010 budget, the US Food and Drug Administration requested a budget of $3.2 billion, which is 19% more than the agency's current budget.
Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president and CEO; more...
May 07, 2009
Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for botulinum toxin producs; C. Richter King joins IAVI; more...